Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047 Meeting Abstract


Authors: Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; Vanak, J. M.; Maragulia, J. C.; Yahalom, J.
Abstract Title: Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 288
Language: English
ACCESSION: WOS:000262104700776
PROVIDER: wos
PUBMED: 22276298
Notes: --- - Meeting Abstract: 775 - Oral Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
MSK Authors
  1. Joachim Yahalom
    394 Yahalom
  2. Carol Portlock
    178 Portlock
  3. Craig Moskowitz
    368 Moskowitz
  4. Ariela Noy
    204 Noy
  5. Steven M Horwitz
    350 Horwitz
  6. Andrew D Zelenetz
    546 Zelenetz
  7. Stephen D Nimer
    339 Nimer
  8. Paul Hamlin
    170 Hamlin
  9. Jill M Vanak
    14 Vanak
  10. David J Straus
    205 Straus